-
Signature
-
/s/ John T. Vaughan, Attorney-in-Fact
-
Issuer symbol
-
DOCS
-
Transactions as of
-
10 Oct 2025
-
Net transactions value
-
-$354,200
-
Form type
-
4
-
Filing time
-
14 Oct 2025, 17:26:44 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Benjamin Regina M. |
Director |
C/O DOXIMITY, INC., 500 THIRD STREET, SAN FRANCISCO |
/s/ John T. Vaughan, Attorney-in-Fact |
14 Oct 2025 |
0001594511 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
DOCS |
Class A Common Stock |
Conversion of derivative security |
|
+5,000 |
+25% |
|
24,839 |
10 Oct 2025 |
Direct |
F1 |
| transaction |
DOCS |
Class A Common Stock |
Sale |
$354,200 |
-5,000 |
-20% |
$70.84 |
19,839 |
10 Oct 2025 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
DOCS |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-5,000 |
-1.4% |
$0.000000 |
351,138 |
10 Oct 2025 |
Class B Common Stock |
5,000 |
$2.21 |
Direct |
F3, F4 |
| transaction |
DOCS |
Class B Common Stock |
Options Exercise |
$0 |
+5,000 |
|
$0.000000 |
5,000 |
10 Oct 2025 |
Class A Common Stock |
5,000 |
|
Direct |
F4 |
| transaction |
DOCS |
Class B Common Stock |
Conversion of derivative security |
$0 |
-5,000 |
-100% |
$0.000000 |
0 |
10 Oct 2025 |
Class A Common Stock |
5,000 |
|
Direct |
F1, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: